Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.13 $244,412 - $390,311
124,700 Added 43.15%
413,700 $877,000
Q4 2021

Feb 14, 2022

BUY
$4.45 - $6.21 $725,350 - $1.01 Million
163,000 Added 129.37%
289,000 $1.5 Million
Q3 2021

Nov 15, 2021

BUY
$6.14 - $10.1 $423,660 - $696,900
69,000 Added 121.05%
126,000 $774,000
Q2 2021

Aug 16, 2021

BUY
$9.04 - $14.19 $515,279 - $808,830
57,000 New
57,000 $576,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $297M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Bridger Management, LLC Portfolio

Follow Bridger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridger Management, LLC with notifications on news.